"We believe that prescribing this combination in routine practice is viable when combined with shared decision-making and strict monitoring of side effects," write Michelle L. M. Mulder, MD, of the ...

Researchers evaluated the impact of different treatment modalities in the prevention of psoriatic arthritis (PsA). Biological agents were found more effective than methotrexate in preventing psoriatic ...

Biosimilar DMARDs offer cost-effective and improved outcomes over leflunomide for RA patients unresponsive to methotrexate. The study used a Markov model with data from 25,099 RA patients to simulate ...

Please provide your email address to receive an email when new articles are posted on . Ixekizumab is efficacious in patients with psoriatic arthritis for up to 1 year, with or without concomitant ...

For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Disease-modifying antirheumatic drugs (DMARDs) are one of the most common therapeutic agent types used in the treatment of rheumatoid arthritis (RA). Despite the fact that DMARDs can retard disease ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Discontinuing methotrexate for 1 week after influenza vaccination offers similar seroprotection ...

A new study presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that after three months of treatment with oral methotrexate, adults with primary knee ...

Credit: Getty Images. The ORAL Shift study enrolled 694 RA patients who were inadequate responders to methotrexate alone. Pfizer announced findings from a phase3b/4 trial evaluating the efficacy and ...

In 777 patients with early arthritis from the French observational ESPOIR cohort, 313 received methotrexate in the first 6 months of follow-up. The mean dose was lower than recommended (12.7 ± 3.8 ...